Trial Outcomes & Findings for A Direct-to-patient Intervention to Increase Rates of Osteoporosis Care (NCT NCT01907269)
NCT ID: NCT01907269
Last Updated: 2018-06-26
Results Overview
We will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the primary outcome.
COMPLETED
NA
2684 participants
6 months post-intervention
2018-06-26
Participant Flow
Participant milestones
| Measure |
Video-based Intervention
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.
Video-based Intervention: Video clips delivered by DVD and Internet
|
Usual Care
|
|---|---|---|
|
6 Month Outcome Measures Post-interventi
STARTED
|
1342
|
1342
|
|
6 Month Outcome Measures Post-interventi
COMPLETED
|
953
|
1053
|
|
6 Month Outcome Measures Post-interventi
NOT COMPLETED
|
389
|
289
|
|
18 Month Outcome Measures Post-intervent
STARTED
|
1178
|
1250
|
|
18 Month Outcome Measures Post-intervent
COMPLETED
|
859
|
970
|
|
18 Month Outcome Measures Post-intervent
NOT COMPLETED
|
319
|
280
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
Baseline characteristics by cohort
| Measure |
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.
Video-based Intervention: Video clips delivered by DVD and Internet
|
Usual Care
n=1342 Participants
|
Total
n=2684 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
74.9 years
STANDARD_DEVIATION 8 • n=1342 Participants
|
74.9 years
STANDARD_DEVIATION 7.9 • n=1342 Participants
|
74.9 years
STANDARD_DEVIATION 7.96 • n=2684 Participants
|
|
Sex: Female, Male
Female
|
1342 Participants
n=1342 Participants
|
1342 Participants
n=1342 Participants
|
2684 Participants
n=2684 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=1342 Participants
|
0 Participants
n=1342 Participants
|
0 Participants
n=2684 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
25 Participants
n=1342 Participants
|
21 Participants
n=1342 Participants
|
46 Participants
n=2684 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
1317 Participants
n=1342 Participants
|
1321 Participants
n=1342 Participants
|
2638 Participants
n=2684 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=1342 Participants
|
0 Participants
n=1342 Participants
|
0 Participants
n=2684 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=1342 Participants
|
0 Participants
n=1342 Participants
|
0 Participants
n=2684 Participants
|
|
Race (NIH/OMB)
Asian
|
13 Participants
n=1342 Participants
|
13 Participants
n=1342 Participants
|
26 Participants
n=2684 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=1342 Participants
|
0 Participants
n=1342 Participants
|
0 Participants
n=2684 Participants
|
|
Race (NIH/OMB)
Black or African American
|
46 Participants
n=1342 Participants
|
52 Participants
n=1342 Participants
|
98 Participants
n=2684 Participants
|
|
Race (NIH/OMB)
White
|
1247 Participants
n=1342 Participants
|
1239 Participants
n=1342 Participants
|
2486 Participants
n=2684 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=1342 Participants
|
0 Participants
n=1342 Participants
|
0 Participants
n=2684 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
36 Participants
n=1342 Participants
|
38 Participants
n=1342 Participants
|
74 Participants
n=2684 Participants
|
|
Region of Enrollment
United States
|
1342 Participants
n=1342 Participants
|
1342 Participants
n=1342 Participants
|
2684 Participants
n=2684 Participants
|
|
Number of Participants who Completed Barriers to Osteoporosis Treatment
|
482 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
482 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
|
Number of Participants who completed Patient's Views about Osteoporosis and Use of Therapy Scale
|
429 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
429 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
|
Number of Participants who Completed Readiness to Behavior Change
|
300 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
300 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
|
Number of Participants who Completed the Osteoporosis Treatment History (tailoring)
|
131 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
0 Participants
Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
131 Participants
n=1342 Participants • Data were only evaluated for intervention tailoring on the "Video-based intervention" arm. "Usual care" data on this measure was not evaluated for the purposes of tailoring, therefore the Row population consists only of the intervention arm (n=1342) and does not include usual care. This results in the row population differing from overall.
|
PRIMARY outcome
Timeframe: 6 months post-interventionPopulation: For the Intent-to-Treat Analysis the data was imputed for non-responders.
We will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the primary outcome.
Outcome measures
| Measure |
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.
Video-based Intervention: Video clips delivered by DVD and Internet
|
Usual Care
n=1342 Participants
|
|---|---|---|
|
Number of Participants That Initiate an Osteoporosis Prescription Medication
|
157 Participants
|
153 Participants
|
SECONDARY outcome
Timeframe: 6 and 18 months post-interventionPopulation: For the Intent-to-Treat Analysis the data was imputed for non-responders.
We will assess the use of calcium and vitamin D by participant. This will be assessed on a self-completed survey. Participants will be asked if they are currently taking a calcium supplement and/or vitamin D supplement.
Outcome measures
| Measure |
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.
Video-based Intervention: Video clips delivered by DVD and Internet
|
Usual Care
n=1342 Participants
|
|---|---|---|
|
Number of Participants Who Reported Use of Calcium and Vitamin D
Vitamin D (6 months)
|
554 Participants
|
562 Participants
|
|
Number of Participants Who Reported Use of Calcium and Vitamin D
Calcium (6 months)
|
427 Participants
|
437 Participants
|
|
Number of Participants Who Reported Use of Calcium and Vitamin D
Vitamin D (18 months)
|
475 Participants
|
572 Participants
|
|
Number of Participants Who Reported Use of Calcium and Vitamin D
Calcium (18 months)
|
249 Participants
|
310 Participants
|
SECONDARY outcome
Timeframe: 6 and 18 months post-interventionPopulation: For the Intent-to-Treat Analysis the data was imputed for non-responders. Surveys for BMD (18 months) included 3 responses. If participants marked option (2) that they had received a BMD, but \> 12 months ago they were excluded from analyses. Thus our overall population analyzed (those marking response 1 or 3) is different than our participant flow.
Self-report of a receipt of a DXA scan (Bone Mineral Density test).
Outcome measures
| Measure |
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.
Video-based Intervention: Video clips delivered by DVD and Internet
|
Usual Care
n=1342 Participants
|
|---|---|---|
|
Number of Participants Who Reported Receipt of Bone Mineral Density (BMD) Testing
BMD (6 months)
|
290 Participants
|
268 Participants
|
|
Number of Participants Who Reported Receipt of Bone Mineral Density (BMD) Testing
BMD (18 months)
|
530 Participants
|
522 Participants
|
SECONDARY outcome
Timeframe: 18 monthsWe will assess the number of participants that self-report the initiation of an osteoporosis prescription medication. It will be assessed using a self-completed survey. Osteoporosis prescription medications that will be assessed include: alendronate, calcitonin, denosumab ibandronate, raloxifene, risedronate, teriparatide, and zoledronic acid. We will not include initiation of estrogen hormone therapies as part of the outcome.
Outcome measures
| Measure |
Video-based Intervention
n=1178 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.
Video-based Intervention: Video clips delivered by DVD and Internet
|
Usual Care
n=1250 Participants
|
|---|---|---|
|
Number of Participants That Initiate an Osteoporosis Prescription Medication
|
136 Participants
|
131 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 6 and 18 months post-interventionPopulation: For the Intent-to-Treat Analysis the data was imputed for non-responders.
Outcome measures
| Measure |
Video-based Intervention
n=1342 Participants
Video-based intervention providing personalized feedback regarding patients' risk of subsequent fractures, customized information regarding osteoporosis care, and messaging to activate patients to become more engaged in improving osteoporosis treatment and doctor-patient communication. This novel content will use "story-telling" delivered via the Internet and DVDs. The content will be uniquely tailored to each person based on their reported barriers to care, age and race/ethnicity. The video-based intervention materials will be augmented by a personal phone call and interactive voice response messaging.
Video-based Intervention: Video clips delivered by DVD and Internet
|
Usual Care
n=1342 Participants
|
|---|---|---|
|
Number of Participants Who Reported Communicating With a Health Care Provider About Osteoporosis Care
Bone health discussion w/provider (6 months)
|
583 Participants
|
573 Participants
|
|
Number of Participants Who Reported Communicating With a Health Care Provider About Osteoporosis Care
Bone health discussion w/provider (18 months)
|
779 Participants
|
806 Participants
|
Adverse Events
Video-based Intervention
Usual Care
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Elizabeth J. Rahn
University of Alabama at Birmingham
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place